Page 1 of Clinical Trials for Drug YM178, 30 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects
Last Updated: March 4, 2009
Condition(s): Overactive Bladder
2
Completed
Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers
Last Updated: March 3, 2009
Condition(s): Pharmacokinetics of YM178
3
Completed
A Study to Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult Volunteers
Last Updated: November 18, 2011
Condition(s): Healthy Subjects; Pharmacokinetics of YM178
4
Completed
A Study to Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive Pill
Last Updated: February 16, 2011
Condition(s): Healthy Volunteers; Pharmacokinetics of Mirabegron
5
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Alone and in Combination for the Treatment of Overactive Bladder
Last Updated: April 20, 2011
Condition(s): Urinary Bladder, Overactive; Urinary Bladder Diseases; Urologic Diseases; Urological Manifestations; Signs and Symptoms
6
Completed
A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females
Last Updated: December 17, 2010
Condition(s): Healthy Subjects
7
Completed
Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder
Last Updated: March 23, 2010
Condition(s): Urinary Bladder, Overactive
8
Completed
A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder
Last Updated: June 14, 2010
Condition(s): Urinary Bladder, Overactive
9
Completed
A Study of YM178 in Subjects With Symptoms of Overactive Bladder
Last Updated: October 10, 2011
Condition(s): Urinary Bladder, Overactive
10
Completed
To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol
Last Updated: November 21, 2011
Condition(s): Pharmacokinetics of Mirabegron; Healthy Subjects
11
Completed
Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist YM178 in Patients With Symptoms of Overactive Bladder
Last Updated: May 10, 2011
Condition(s): Urinary Bladder, Overactive
12
Completed
A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously
Last Updated: February 16, 2011
Condition(s): Healthy Volunteers; Pharmacokinetics of Mirabegron
13
Completed
To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together
Last Updated: November 21, 2011
Condition(s): Pharmacokinetics of Mirabegron; Healthy Subjects
14
Completed
Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Patients With Symptoms of Overactive Bladder
Last Updated: April 15, 2010
Condition(s): Urinary Bladder, Overactive
15
Completed
A Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder
Last Updated: March 31, 2011
Condition(s): Urinary Bladder, Overactive
16
Completed
A Study of YM178 in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
Last Updated: August 24, 2009
Condition(s): Lower Urinary Tract Symptoms; Bladder Outlet Obstruction
17
Completed
A Study of YM178 in Patients With Symptomatic Overactive Bladder
Last Updated: December 13, 2011
Condition(s): Urinary Bladder, Overactive
18
Completed
A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.
Last Updated: January 26, 2011
Condition(s): Healthy Volunteers; Pharmacodynamics of Mirabegron
19
Completed
To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females
Last Updated: November 21, 2011
Condition(s): Pharmacokinetics; Healthy Subjects
20
Completed
A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin
Last Updated: December 8, 2011
Condition(s): Cardiovascular; Healthy Subjects; Pharmacokinetics

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+YM178

Page 1 of Clinical Trials for Drug YM178, 30 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About